Daridorexant Synthesis and Manufacturing
The synthesis of daridorexant involves a multi-step chemical process. Key intermediates are formed through a series of reactions, ultimately leading to the final active pharmaceutical ingredient [1]. The specific details of each synthetic step, including reagents, reaction conditions, and purification methods, are proprietary information held by the manufacturer.
How is Daridorexant Protected by Patents?
Daridorexant is protected by various patents that cover its composition of matter, methods of use, and manufacturing processes. These patents are crucial for granting the drug's developer, Idorsia Pharmaceuticals, market exclusivity. Patent information for daridorexant and its related compounds can be found on specialized databases like DrugPatentWatch.com [2].
When Does Daridorexant's Patent Exclusivity End?
The duration of patent exclusivity for daridorexant varies depending on the specific patents filed and their expiration dates. Typically, patents have a lifespan of 20 years from the filing date, but extensions can be granted under certain circumstances, such as for pharmaceutical products. Detailed information on the expiration timelines for daridorexant's patents can be accessed through patent tracking resources [2].
What Are the Potential Challenges to Daridorexant's Patents?
Pharmaceutical patents can be challenged by competitors, often generic drug manufacturers, through various legal and administrative proceedings. These challenges may argue that the patent is invalid, not infringed upon, or that there is insufficient novelty or inventiveness. Such challenges can lead to early market entry for generic versions of the drug.
Are There Any Authorized Generics or Biosimilars for Daridorexant?
As of now, there are no authorized generic versions or biosimilars of daridorexant available. The development and approval of generics and biosimilars typically occur after the expiration of primary patents, or through specific licensing agreements.
What Clinical Data Supports Daridorexant's Efficacy and Safety?
Clinical trials have demonstrated daridorexant's efficacy in improving sleep onset and maintenance for individuals with insomnia disorder. The drug's safety profile has also been evaluated, with common side effects including somnolence, headache, and fatigue [3]. Further detailed clinical data is available in the drug's prescribing information and published scientific literature.
Who Manufactures Daridorexant?
Daridorexant is developed and manufactured by Idorsia Pharmaceuticals. The company holds the primary rights to produce and market the drug.
---
Sources:
1. Information on drug synthesis steps is generally proprietary.
2. DrugPatentWatch.com
3. Prescribing information for daridorexant.